All In Biotech

Drug Trial Radar · NCT02883569

Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain

Randomized Control Trial. Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain

Last checked: Nov 19, 2026Latest source record: Apr 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,102 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,102

Actual

Start

Sep 2016

Primary completion

Dec 2020

Study completion Dec 2021

Sponsor

Lead sponsor
Seoul National University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Seoul National University Bundang Hospital; Gangnam Severance Hospital; Severance Hospital; Korea University Guro Hospital
First posted
Aug 30, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Crossover
Masking
Double (investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Purpose: Comparative effectiveness research (CER) between surgical and non-surgical treatment for patients with low back pain Hypothesis: There will be significant differences in surgical and non-surgical treatment effect in patients who need operation for herniated intervertebral disc and spinal stenosis.

Conditions

  • Low Back Pain

Interventions

  • open or endoscopic discectomyProcedure

    FDA approved surgical procedures

  • epidural blockProcedure

    epidural block

  • exerciseOther

    educated exercise

  • ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenacDrug

    FDA approved medication such as ibuprofen, naxoprofen etc.

  • decompressionProcedure

    FDA approved surgical procedure such as lamiectom and, laminotomy

  • instrumentation and fusionProcedure

    FDA approved surgical procedure such as PLIF, ALIF, DLIF, OLI and TLIF

  • codeine, oxycontine, IRcodone, TramadolDrug

    FDA approved opioid drug such as codeine, oxycontin, IRcodon

  • epidural adhesiolysisProcedure

    FDA approved epidural adhesiolysis with catheter or endoscope

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Compare the change of pain score after treatmentTime frame: baseline and 24 months after treatment.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Seoul National University Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.